Natural Sleep Aid Revenue and Competitors
Estimated Revenue & Valuation
- Natural Sleep Aid's estimated annual revenue is currently $1.9M per year.
- Natural Sleep Aid's estimated revenue per employee is $162,000
Employee Data
- Natural Sleep Aid has 12 Employees.
- Natural Sleep Aid grew their employee count by 20% last year.
Natural Sleep Aid's People
Name | Title | Email/Phone |
---|
Natural Sleep Aid Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.1M | 33 | 0% | N/A | N/A |
#2 | $21.3M | 79 | 7% | N/A | N/A |
#3 | $387.8M | 1026 | -2% | N/A | N/A |
#4 | $0.2M | 8 | -27% | N/A | N/A |
#5 | $3.1M | 19 | -10% | N/A | N/A |
#6 | $5.3M | 28 | 4% | N/A | N/A |
#7 | $2.6M | 16 | -48% | N/A | N/A |
#8 | $9.7M | 45 | 7% | N/A | N/A |
#9 | $8.4M | 39 | 8% | N/A | N/A |
#10 | $10.4M | 48 | 9% | N/A | N/A |
What Is Natural Sleep Aid?
Build your holistic, long term sleep health, starting tonight. Proper is committed to: 1. Natural, healthy solutions that help you achieve better sleep, and, therefore, better health and happiness. 2. Bringing the best of science, data, and technology together for a more effective, holistic & personalized experience. 3. Constant evolution and innovation.
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Natural Sleep Aid News
This sleeping aid only consists of natural ingredients, so you never worry about side effects. The magnesium content allows you to sleep...
Gluconite falls under natural sleep aids because it delivers essential nutrients that instantly push the user to fall asleep and dive into the...
Natural Stacks Dream CBD; Harmonium Sleep Support; CBDfx CBD Gummies with Melatonin; Healthy Back Institute SleepZyme; Neurohacker Qualia Night...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 12 | -83% | N/A |
#2 | $1.5M | 12 | -29% | N/A |
#3 | $35M | 12 | -61% | N/A |
#4 | $0.6M | 12 | -8% | $5.2M |
#5 | $1.6M | 12 | -14% | N/A |